Estradiol-sertraline synergy in ovariectomized rats

Psychoneuroendocrinology

Volumn 33, Issue 8, 2008, Pages 1051-1060

  Sell, Stacy L ^a   Craft, Rebecca M ^b   Seitz, Patricia K ^a   Stutz, Sonja J ^a   Cunningham, Kathryn A ^a   Thomas, Mary L ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Antidepressant; Estrogen; Forced swim test; Selective serotonin reuptake inhibitor; Serotonin receptors; Serotonin transporter

Indexed keywords

ESTRADIOL; IMIPRAMINE; MESSENGER RNA; SEROTONIN 1A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SERTRALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLIMBING; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG IMPLANTATION; DRUG POTENTIATION; ESTRADIOL BLOOD LEVEL; FEMALE; FORCED SWIMMING TEST; GENE EXPRESSION; HIPPOCAMPUS; LOCOMOTION; MESENCEPHALON; NONHUMAN; OVARIECTOMY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; VAGINA CYTOLOGY; WESTERN BLOTTING;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; DEPRESSION; DRUG EVALUATION, PRECLINICAL; DRUG SYNERGISM; ESTRADIOL; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; MESENCEPHALON; OVARIECTOMY; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SERTRALINE; VAGINA;

EID: 49049115706     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2008.05.006     Document Type: Article

References (51)

1. 1A receptors. Behav. Brain Res. 163 (2005) 18-25
2. 1B mRNA in rat dorsal raphe nucleus reverses rapidly after drug discontinuation. J. Neurosci. Res. 61 (2000) 82-87
3. Bethea C.L., Mirkes S.J., Su A., and Michelson D. Effects of oral estrogen, raloxifene and arzoxifene on gene expression in serotonin neurons of macaques. Psychoneuroendocrinology 27 (2002) 431-445
4. Benvenga M.J., and Leander J.D. Antidepressant-like effect of LY228729 as measured in the rodent forced swim paradigm. Eur. J. Pharmacol. 239 (1993) 249-252
5. Borsini F., and Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity?. Psychopharmacology 94 (1988) 147-160
6. Borsini F. Role of the serotonergic system in the forced swimming test. Neurosci. Biobehav. Rev. 19 (1995) 377-395
7. Bridges R.S. A quantitative analysis of the roles of dosage, sequence, and duration of estradiol and progesterone exposure in the regulation of maternal behavior in the rat. Endocrinology 114 (1984) 930-940
8. Craft R.M. Modulation of pain by estrogens. Pain 132 (2007) S3-S12
9. Cryan J.F., Valentino R.J., and Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci. Biobehav. Rev. 29 (2005) 547-569
10. Cyr M., Landry M., and Di Paolo T. Modulation by estrogen-receptor directed drugs of 5-hydroxytryptamine-2A receptors in rat brain. Neuropsychopharmacology 23 (2000) 69-78
11. Detke M.J., Rickels M., and Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl.) 121 1 (1995) 66-72
12. Dvorak Z., Pascussi J.M., and Modriansky M. Approaches to messenger RNA detection-comparison of methods. Biomed. Papers 147 2 (2003) 131-135
13. Estrada-Camarena E., Fernandez-Guasti A., and Lopez-Rubalcava C. Antidepressant-like effect of different estrogenic compounds in the forced swimming test. Neuropsychopharmacology 28 (2003) 830-838
14. Estrada-Camarena E., Fernandez-Guasti A., and Lopez-Rubalcava C. Interaction between estrogens and antidepressants in the forced swimming test in rats. Psychopharmacology 173 (2004) 139-145
15. 1A and estrogen receptors in the rat forced swimming test. Psychoneuroendocrinology 31 (2006) 905-914
16. 1A receptor in the antidepressant-like effects of estrogens in the forced swimming test. Neuropsychopharmacology 31 (2006) 247-255
17. L dopamine receptors by agonists and antagonists in transfected HEK-293 cells. J. Pharmacol. Exp. Ther. 271 (1994) 1574-1582
18. 1A-receptor binding in the brain of cyclic and ovariectomized female rats. J. Neuroendocrinol. 11 (1999) 243-249
19. Frazer A. Pharmacology of antidepressants. J. Clin. Psychopharm. 17 (1997) 2S-18S
20. Freeman M.E. The neuroendocrine control of the ovarian cycle of the rat. In: Knobil E., and Neill J. (Eds). The Physiology of Reproduction (1988), Raven Press, New York 1893-1928
21. Halbreich U., and Kahn L.S. Role of estrogen in the aetiology and treatment of mood disorders. CNS Drugs 15 (2001) 797-817
22. Heffner T.G., Hartman J.A., and Seiden L.S. A rapid method for the regional dissection of the rat brain. Pharmacol. Biochem. Behav. 13 (1980) 453-456
23. Hope W.G., Bruns M.E., and Thomas M.L. Regulation of duodenal insulin-like growth factor I and active calcium transport by ovariectomy in female rats. Proc. Soc. Exp. Biol. Med. 200 (1992) 528-535
24. Jacobs P.A., and Hyland M.E. An evaluation of the benefits of taking hormone replacement therapy with other prescription drugs. Maturitas 46 (2003) 273-281
25. Kirby L.G., Pan Y.-Z., Freeman-Daniels E., Rani S., Nunan J.D., Akanwa A., and Beck S.G. Cellular effects of swim stress in the dorsal raphe nucleus. Psychoneuroendocrinology 32 (2007) 712-723
26. Kornstein S.G., Schatzberg A.F., Thase M.E., Yonkers K.A., McCullough J.P., Keitner G.I., Gelenberg A.J., Davis S.M., Harrison W.M., and Keller M.B. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am. J. Psychiatry 157 (2000) 1445-1452
27. 1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology 39 (2000) 110-122
28. Lopez J.F., Chalmers D.T., Vazquez D.M., Watson S.J., and Akil H. Serotonin transporter mRNA in rat brain is regulated by classical antidepressants. Biol. Psychiatry 35 (1994) 287-290
29. 1A receptor binding and G protein activation in female monkeys. Neuropsychopharmacology 27 (2002) 12-24
30. Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav. Pharmacol. 8 (1997) 523-532
31. McQueen J.K., Wilson H., and Fink G. Estradiol-17β increases serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain. Mol. Brain Res. 45 (1997) 13-23
32. 1A receptors in the brain by estrogens: regional variations in antagonism by ICI 182,780. Neuropharmacology 44 (2003) 584-591
33. Nagata H., Nozaki M., and Nakano H. Short-term combinational therapy of low-dose estrogen with selective serotonin re-uptake inhibitor (fluvoxamine) for oophorectimized women with hot flashes and depressive tendencies. J. Obstet. Gynaecol. Res. 31 (2005) 107-114
34. 1B mRNA in a sequential manner in the rat dorsal raphe nucleus. Neuropsychopharmacology 15 (1996) 515-522
35. Noble R.E. Depression in women. Metab. Clin. Exp. 54 (2005) 49-52
36. 1A receptor mRNA expression in the limbic system of female rats. Mol. Brain Res. 55 (1998) 169-172
37. Page M.E., Detke M.J., Dalvi A., Kirby L.G., and Lucki I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology 147 (1999) 162-167
38. Pau K.Y., Hess D.L., Kohama S., Bao J., Pau C.Y., and Spies H.G. Oestrogen upregulates noradrenaline release in the mediobasal hypothalamus and tyrosine hydroxylase gene expression in the brainstem of ovariectomized rhesus macaques. J. Neuroendocrinol. 12 9 (2000) 899-909
39. Porsolt R.D., Le Pichon M., and Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 266 (1977) 730-732
40. 1A receptor mRNA after irreversible inactivation with EEDQ. Mol. Brain Res. 38 (1996) 233-242
41. Rasgon N.L., Dunkin J., Fairbanks L., Altshuler L.L., Troung C., Elman S., Wroolie T.E., Brunhuber M.V., and Rapkin A. Estrogen and response to sertraline in postmenopausal women with major depressive disorder: a pilot study. J. Psychiatric Res. 41 (2006) 338-343
42. Schneider L.S., Small G.W., and Clary C.M. Estrogen replacement therapy and antidepressant response to sertraline in older depressed women. Am. J. Geriatr. Psychiatry 9 (2001) 393-399
43. Sell S.L., Scalzitti J.M., Thomas M.L., and Cunningham K.A. Influence of ovarian hormones and estrous cycle on the behavioral response to cocaine in female rats. J. Pharmacol. Exp. Ther. 293 (2000) 879-886
44. Sell S.L., Thomas M.L., and Cunningham K.A. Influence of estrous cycle and estradiol on behavioral sensitization to cocaine in female rats. Drug Alcohol. Depend 67 (2002) 281-290
45. Shaw A.M., Boules M., Zhang Y., Williams K., Robinson J., Carlier P.R., and Richelson E. Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050. Eur. J. Pharmacol. 555 1 (2007) 30-36
46. Stoffel E.C., Ulibarri C.M., and Craft R.M. Gonadal steroid hormone modulation of nociception, morphine antinociception and reproductive indices in male and female rats. Pain 103 (2003) 285-302
47. Smith M.S., Freeman M.F., and Neill J.D. The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gonadotropin, corpus luteum of pseudopregnancy. Endocrinology 96 (1975) 219-226
48. Sumner B.E.H., Grant K.E., Rosie R., Hegele-Hartung Ch., Fritzemeier K.H., and Fink G. Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine2A receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement. Mol. Brain Res. 73 (1999) 119-128
49. Zanardi R., Rossini D., Magri L., Malaguti A., Colombo C., and Smeraldi E. Response to SSRIs and role of the hormonal therapy in post-menopausal depression. Eur. Neuropsychopharmacol. 17 (2007) 400-405
50. Zhou W., Cunningham K.A., and Thomas M.L. Estrogen regulation of gene expression in the brain: a possible mechanism altering the response to psychostimulants in female rats. Mol. Brain Res. 100 (2002) 75-83
51. Zhou W., Koldzic-Zivanovic N., Clarke C.H., de Beun R., Wassermann K., Bury P.S., Cunningham K.A., and Thomas M.L. Selective estrogen receptor modulator effects in the rat brain. Neuroendocrinology 75 (2002) 24-33